140 related articles for article (PubMed ID: 11300448)
21. Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
Vitale C; Fini M; Leonardo F; Rossini P; Cerquetani E; Onorati D; Rosano GM
Maturitas; 2001 Dec; 40(3):239-45. PubMed ID: 11731185
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
[TBL] [Abstract][Full Text] [Related]
23. Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study.
Cagnacci A; Tarquini R; Perfetto F; Arangino S; Zanni AL; Cagnacci P; Facchinetti F; Volpe A
Maturitas; 2003 Feb; 44(2):117-24. PubMed ID: 12590007
[TBL] [Abstract][Full Text] [Related]
24. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease.
Collins P; Rosano GM; Sarrel PM; Ulrich L; Adamopoulos S; Beale CM; McNeill JG; Poole-Wilson PA
Circulation; 1995 Jul; 92(1):24-30. PubMed ID: 7788912
[TBL] [Abstract][Full Text] [Related]
25. Acute administration of 17beta-estradiol improves endothelium-dependent vasodilation in postmenopausal women.
Lima SM; Aldrighi JM; Consolim-Colombo FM; Mansur Ade P; Rubira MC; Krieger EM; Ramires JA
Maturitas; 2005 Apr; 50(4):266-74. PubMed ID: 15780525
[TBL] [Abstract][Full Text] [Related]
26. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.
Squadrito F; Altavilla D; Crisafulli A; Saitta A; Cucinotta D; Morabito N; D'Anna R; Corrado F; Ruggeri P; Frisina N; Squadrito G
Am J Med; 2003 Apr; 114(6):470-6. PubMed ID: 12727580
[TBL] [Abstract][Full Text] [Related]
27. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
[TBL] [Abstract][Full Text] [Related]
28. Does sublingual 17 beta-oestradiol have any effects on exercise capacity and myocardial ischaemia in post-menopausal women with stable coronary artery disease?
al-Khalili F; Landgren BM; Eksborg S; Franco-Cereceda A; Schenck-Gustafsson K
Eur Heart J; 1998 Jul; 19(7):1019-26. PubMed ID: 9717036
[TBL] [Abstract][Full Text] [Related]
29. Acute administration of 17beta-estradiol reduces endothelin-1 release during pacing-induced ischemia.
Rosano GM; Gebara O; Sheiban I; Silvestri A; Wajngarten M; Vitale C; Aldrighi JM; Ramires AF; Fini M; Mercuro G
Int J Cardiol; 2007 Mar; 116(1):34-9. PubMed ID: 16814412
[TBL] [Abstract][Full Text] [Related]
30. In normal postmenopausal women physiologic estrogen replacement therapy fails to improve exercise tolerance: a randomized, double-blind, placebo-controlled, crossover trial.
Snabes MC; Herd JA; Schuyler N; Dunn K; Spence DW; Young RL
Am J Obstet Gynecol; 1996 Jul; 175(1):110-4. PubMed ID: 8694035
[TBL] [Abstract][Full Text] [Related]
31. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.
Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
Am J Cardiol; 1995 Feb; 75(4):264-8. PubMed ID: 7832136
[TBL] [Abstract][Full Text] [Related]
32. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
33. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
[TBL] [Abstract][Full Text] [Related]
34. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms.
Roqué M; Heras M; Roig E; Masotti M; Rigol M; Betriu A; Balasch J; Sanz G
J Am Coll Cardiol; 1998 Jan; 31(1):139-43. PubMed ID: 9426032
[TBL] [Abstract][Full Text] [Related]
35. Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography.
Strachan FE; Newby DE; Sciberras DG; McCrea JB; Goldberg MR; Webb DJ
Br J Clin Pharmacol; 2002 Oct; 54(4):386-94. PubMed ID: 12392586
[TBL] [Abstract][Full Text] [Related]
36. Acute effects of transdermal estrogen on hemodynamic and vascular reactivity in elderly postmenopausal healthy women.
Manhem K; Brandin L; Ghanoum B; Rosengren A; Gustafsson H
J Hypertens; 2003 Feb; 21(2):387-94. PubMed ID: 12569270
[TBL] [Abstract][Full Text] [Related]
37. Effect of estrogen replacement therapy on cardiac function in postmenopausal women with and without flushes.
Beljic T; Babic D; Marinkovic J; Prelevic GM
Gynecol Endocrinol; 1999 Apr; 13(2):104-12. PubMed ID: 10399055
[TBL] [Abstract][Full Text] [Related]
38. Continuous-combined oral estradiol/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial.
Davison SL; Bell RJ; Robinson PJ; Jane F; Leech J; Maruff P; Egan GF; Davis SR
Menopause; 2013 Oct; 20(10):1020-6. PubMed ID: 23591255
[TBL] [Abstract][Full Text] [Related]
39. Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women.
Sung BH; Ching M; Izzo JL; Dandona P; Wilson MF
J Hypertens; 1999 Apr; 17(4):523-8. PubMed ID: 10404954
[TBL] [Abstract][Full Text] [Related]
40. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
